Lincoln Pharmaceuticals Limited (BOM:531633)
646.50
+24.95 (4.01%)
At close: Apr 28, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 13.49 billion as of April 29, 2026. Its market cap has increased by 19.71% in one year.
Market Cap
13.49B
Enterprise Value
11.17B
Revenue
6.52B
Ranking
n/a
PE Ratio
15.36
Stock Price
646.50
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 13.49B, an increase of 9,613.15%. That is a compound annual growth rate of 23.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 12.96B |
| Syncom Formulations (India) | 13.11B |
| TTK Healthcare | 12.72B |
| Venus Remedies | 12.17B |
| Fredun Pharmaceuticals | 11.58B |
| Kwality Pharmaceuticals | 16.73B |
| Amrutanjan Health Care | 16.81B |
| Fermenta Biotech | 9.25B |